2.29
0.87%
-0.02
Handel nachbörslich:
2.29
Finanzdaten der Protara Therapeutics Inc-Aktie (TARA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
7.34%
11.85
|
11.04 | 10.70 | 12.14 | 9.732 |
Operating Income/Loss |
7.34%
-11.85
|
-11.04 | -10.70 | -12.14 | -9.732 |
Nonoperating Income/Loss |
7.80%
0.756
|
0.82 | 0.84 | 0.846 | 0.687 |
Income/Loss From Continuing Operations Before Tax |
53.72%
-11.10
|
-23.97 | -9.86 | -11.29 | -9.045 |
Income/Loss From Continuing Operations After Tax |
8.55%
-11.10
|
-10.22 | -9.86 | -11.29 | -9.045 |
Net Income/Loss
|
8.55%
-11.10
|
-10.22 | -9.86 | -11.29 | -9.045 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
100.87K%
11.42
|
0.0113 | 11.35 | 11.31 | 11.30 |
Diluted Average Shares |
100.87K%
11.42
|
0.0113 | 11.35 | 11.31 | 11.30 |
Basic Earnings Per Share |
7.78%
-0.97
|
-0.90 | -0.87 | -1.00 | -0.80 |
Diluted Earnings Per Share |
7.78%
-0.97
|
-0.90 | -0.87 | -1.00 | -0.80 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):